Polyhedron, Год журнала: 2021, Номер 198, С. 115060 - 115060
Опубликована: Янв. 27, 2021
Язык: Английский
Polyhedron, Год журнала: 2021, Номер 198, С. 115060 - 115060
Опубликована: Янв. 27, 2021
Язык: Английский
Molecular Diversity, Год журнала: 2022, Номер 26(5), С. 2825 - 2845
Опубликована: Апрель 9, 2022
Язык: Английский
Процитировано
80Journal of Coordination Chemistry, Год журнала: 2023, Номер 76(5-6), С. 546 - 580
Опубликована: Март 19, 2023
The discovery of new chemical entities having enhanced bioactivities and improved functionalities to overcome the prevailing antibiotic resistance emerging diseases has evolved as one most needed research areas in pharmaceutical field. Intensive been done on metal-based drugs a result, metal complexes various Schiff bases are acknowledged potential area bioinorganic chemistry account their promising applicable uses several fields science. base sulfonamides versatile pharmacophores forming stable compounds by coordinating with metals oxidation states. As therapeutic candidates, they have actively used many applications including antifungal, analgesic, anti-inflammatory, antiviral, antitumor, antibacterial more. There worldwide risk drug medical field pathogenic microbes capable deactivating substances. This review summarizes developments that taken place from 2008 2022 activities derived compounds.
Язык: Английский
Процитировано
47Bioorganic Chemistry, Год журнала: 2021, Номер 113, С. 105009 - 105009
Опубликована: Май 23, 2021
Язык: Английский
Процитировано
98International Journal of Biological Macromolecules, Год журнала: 2020, Номер 163, С. 1970 - 1988
Опубликована: Сен. 13, 2020
Язык: Английский
Процитировано
97Chemistry & Biodiversity, Год журнала: 2021, Номер 18(4)
Опубликована: Фев. 23, 2021
Abstract A series of six N ‐carbamimidoyl‐4‐(3‐substituted phenylureido)benzenesulfonamide derivatives were synthesized by reaction sulfaguanidine with aromatic isocyanates. In vitro and in silico inhibitory effects the novel ureido‐substituted investigated spectrophotometric methods for α‐glycosidase (α‐GLY), acetylcholinesterase (AChE), butyrylcholinesterase (BChE) enzymes associated diabetes mellitus (DM) Alzheimer's disease (AD). ‐Carbamimidoyl‐4‐{[(3,4‐dichlorophenyl)carbamoyl]amino}benzene‐1‐sulfonamide ( 2f ) showed AChE BChE effects, K I values 515.98±45.03 nM 598.47±59.18 nM, respectively, while ‐carbamimidoyl‐4‐{[(3‐chlorophenyl)carbamoyl]amino}benzene‐1‐sulfonamide 2e strong α‐GLY effect, 103.94±13.06 nM. The antidiabetic compounds are higher than their anti‐Alzheimer's because inhibition effect on diabetic enzyme is greater esterase enzymes. Indeed, metabolic important treatment DM AD.
Язык: Английский
Процитировано
82Archiv der Pharmazie, Год журнала: 2021, Номер 354(12)
Опубликована: Сен. 27, 2021
New hybrid thiazolyl-pyrazoline derivatives (4a-k) were obtained through a facile and versatile synthetic procedure, their inhibitory effects on the human carbonic anhydrase (hCA) isoforms I II as well acetylcholinesterase (AChE) determined. All new thiazolyl-pyrazolines showed activity at nanomolar levels hCA I, II, AChE inhibitors, with KI values in range of 13.35-63.79, 7.01-115.80, 17.89-48.05 nM, respectively. 1-[4-(4-Cyanophenyl)thiazol-2-yl]-3-(4-piperidinophenyl)-5-(4-fluorophenyl)-2-pyrazoline (4f) 1-(4-phenylthiazol-2-yl)-3-(4-piperidinophenyl)-5-(4-fluorophenyl)-2-pyrazoline (4a) against hCAs 1-[4-(4-chlorophenyl)thiazol-2-yl]-3-(4-piperidinophenyl)-5-(4-fluorophenyl)-2-pyrazoline (4d) 1-[4-(4-nitrophenyl)thiazol-2-yl]-3-(4-piperidinophenyl)-5-(4-fluorophenyl)-2-pyrazoline (4b) identified highly potent superior to standard drugs, acetazolamide tacrine, Compounds 4a-k also evaluated for cytotoxic L929 mouse fibroblast (normal) cell line. Moreover, comprehensive ligand-receptor interaction prediction was performed using ADME-Tox, Glide XP, MM-GBSA modules Schrödinger Small-Molecule Drug Discovery Suite elucidate potential binding modes inhibitors these metabolic enzymes.
Язык: Английский
Процитировано
72Open Chemistry, Год журнала: 2021, Номер 19(1), С. 347 - 357
Опубликована: Янв. 1, 2021
Abstract In an effort to identify potent aldose reductase (AR) inhibitors, 5-(arylidene)thiazolidine-2,4-diones ( 1 – 8 ), which were prepared by the solvent-free reaction of 2,4-thiazolidinedione with aromatic aldehydes in presence urea, examined for their vitro AR inhibitory activities and cytotoxicity. 5-(2-Hydroxy-3-methylbenzylidene)thiazolidine-2,4-dione 3 ) was most inhibitor this series, exerting uncompetitive inhibition a K i value 0.445 ± 0.013 µM. The IC 50 compound L929 mouse fibroblast cells determined as 8.9 0.66 µM, pointing out its safety inhibitor. Molecular docking studies suggested that exhibited good affinity binding site (PDB ID: 4JIR). Based upon silico absorption, distribution, metabolism, excretion data, is predicted have favorable pharmacokinetic features. Taking into account stands potential orally bioavailable management diabetic complications well nondiabetic diseases.
Язык: Английский
Процитировано
67Bioorganic Chemistry, Год журнала: 2021, Номер 117, С. 105473 - 105473
Опубликована: Ноя. 8, 2021
Язык: Английский
Процитировано
62Molecular Diversity, Год журнала: 2022, Номер 27(4), С. 1713 - 1733
Опубликована: Сен. 14, 2022
Язык: Английский
Процитировано
57Molecular Diversity, Год журнала: 2022, Номер 27(4), С. 1735 - 1749
Опубликована: Сен. 22, 2022
Язык: Английский
Процитировано
51